ALNYLAM PHARMACEUTICALS, INC. 8-K

Company

ALNYLAM PHARMACEUTICALS, INC.

Filed

November 5, 2020

Period of Report

November 5, 2020

Accession Number

0001157523-20-001446

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →